Jane Street
GLMD icon

Jane Street’s Galmed Pharmaceuticals GLMD Stock Holding History

Jane Street’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,056
Closed -$8.06K – 12128
2026
Q1 		$8.06K Buy
2,056
+539
+36% +$2.91K ﹤0.01% 11322
2025
Q4 		$9.11K Buy
+1,517
New +$14.2K ﹤0.01% 10854
2023
Q2 		– Sell
-9
Closed -$5.63K – 9000
2023
Q1 		$5.63K Sell
9
-10
-53% -$8.59K ﹤0.01% 8796
2022
Q4 		$13.6K Buy
19
+9
+90% +$4.71K ﹤0.01% 8691
2022
Q3 		$4K Buy
+10
New +$6.83K ﹤0.01% 9468
2018
Q3 		– Sell
-17
Closed -$284K – 5322
2018
Q2 		$284K Buy
+17
New +$197K ﹤0.01% 4183

Other funds holding GLMD

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jane Street's GLMD Position: Q2 2026 in Review

Jane Street sold out of Galmed Pharmaceuticals (GLMD) in Q2 2026, closing a stake of 2,056 shares — an estimated $8.06K sold.

Jane Street first reported a position in GLMD in Q2 2018 and held it in 6 quarters. The position peaked at $284K in Q2 2018. 11 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.

  • Jane Street reported no remaining Galmed Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 2,056 Galmed Pharmaceuticals shares in Q2 2026, an estimated $8.06K.
  • Jane Street first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 6 quarters.
  • Jane Street's Galmed Pharmaceuticals position peaked at $284K in Q2 2018.
  • 11 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.